Clinical Significance of Immunohistochemical Markers of Diffuse Large B-Cell Lymphoma In the Rituximab Era.

被引：0
|
作者：
Hayama, Miyuki [1 ]
Okamoto, Masataka [2 ]
Hagiwara, Yuki [1 ]
Tanae, Ken [1 ]
Kohri, Mika [1 ]
Takahashi, Naoki [1 ]
Yoshino, Tadashi [2 ]
Ohshima, Koichi [2 ]
Niitsu, Nozomi [1 ]
机构：
[1] Saitama Med Univ, Int Med Ctr, Dept Hematol, Hidaka, Japan
[2] ALTSG, Nagoya, Aichi, Japan
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：752 / 752
页数：1
相关论文
共 50 条
  • [31] Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma
    Coleman, Morton
    Lammers, Philip E.
    Ciceri, Fabio
    Jacobs, Ira A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (04): : 175 - 181
  • [32] Clinical Significance of CMYC Rearrangement in Diffuse Large B-Cell Lymphoma
    Caponetti, G. C.
    Dave, B.
    Smith, L.
    Meyer, P.
    Bast, M.
    Bierman, P.
    Bociek, G.
    Vose, J.
    Armitage, J. O.
    Aoun, P.
    Fu, K.
    Greiner, T.
    Chan, W. C.
    Weisenburger, D.
    LABORATORY INVESTIGATION, 2011, 91 : 288A - 288A
  • [33] Predictors of early vs late diffuse large B cell lymphoma (DLBCL) relapses in the Rituximab era.
    Koh, Jasmin Jiemin
    Lim, Soon Thye
    Sultana, Rehena
    Tang, Tiffany Pool Ling
    Tao, Miriam
    Mohamad, Farid
    Poon, Eileen Yi Ling
    Chan, Jason Yongsheng
    Somasundaram, Nagavalli
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
    Seo, Seyoung
    Hong, Jung Yong
    Yoon, Shinkyo
    Yoo, Changhoon
    Park, Ji Hyun
    Lee, Jung Bok
    Park, Chan-Sik
    Huh, Jooryung
    Lee, Yoonse
    Kim, Kyung Won
    Ryu, Jin-Sook
    Kim, Seok Jin
    Kim, Won Seog
    Yoon, Dok Hyun
    Suh, Cheolwon
    ONCOTARGET, 2016, 7 (47) : 76934 - 76943
  • [35] Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era
    Dalia, Samir
    Chavez, Julio
    Little, Bryan
    Bello, Celeste
    Fisher, Kate
    Lee, Ji-Hyun
    Chervenick, Paul
    Sokol, Lubomir
    Sotomayor, Eduardo
    Shah, Bijal
    ANNALS OF HEMATOLOGY, 2014, 93 (08) : 1305 - 1312
  • [36] Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era
    Nowakowski, Grzegorz S.
    Maurer, Matthew J.
    Habermann, Thomas M.
    Ansell, Stephen M.
    Macon, William R.
    Ristow, Kay M.
    Allmer, Cristine
    Slager, Susan L.
    Witzig, Thomas E.
    Cerhan, James R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 412 - 417
  • [37] Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era
    Samir Dalia
    Julio Chavez
    Bryan Little
    Celeste Bello
    Kate Fisher
    Ji-Hyun Lee
    Paul Chervenick
    Lubomir Sokol
    Eduardo Sotomayor
    Bijal Shah
    Annals of Hematology, 2014, 93 : 1305 - 1312
  • [38] Clinical Characteristics and Outcome of Transformed Diffuse Large B-Cell Lymphoma in the Rituximab Era: A SEER Database Analysis
    Wang, Yucai
    Wang, Yanru
    Wang, Michael
    Thanarajasingam, Gita
    Thompson, Carrie
    Nowakowski, Grzegorz
    Habermann, Thomas
    Ansell, Stephen
    Witzig, Thomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S362 - S362
  • [39] Outcomes of Patients with Refractory/Relapsed Diffuse Large B-Cell Lymphoma Who Progress After Autologous Stem Cell Transplantation in the Rituximab Era.
    Nagle, Sarah J.
    Woo, Kaitlin
    Mick, Rosemarie
    Schuster, Stephen J.
    Nasta, Sunita D.
    Stadtmauer, Edward A.
    Svoboda, Jakub
    BLOOD, 2012, 120 (21)
  • [40] PHARMACOKINETICS OF RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Rozman, S.
    Grabnar, I.
    Novakovic, S.
    Mrhar, A.
    Novakovic, B. Jezersek
    HAEMATOLOGICA, 2017, 102 : 688 - 688
12345